Covered recipient · General Payments record
DAVID A FELDMAR
Allopathic & Osteopathic Physicians Surgery
General Payments · PY2018–2024
$8,476.45
- Reported across 287 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,711.52 | 49 |
| Travel and Lodging | $627.24 | 3 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Solventum Corporation | $1,156.39 | 8 |
| ABBVIE INC. | $747.51 | 28 |
| REVANCE THERAPEUTICS, INC. | $83.99 | 3 |
| MERZ NORTH AMERICA, INC. | $75.95 | 2 |
| Novo Nordisk AS | $65.55 | 3 |
| TELA Bio, Inc. | $64.74 | 3 |
| LifeNet Health | $35.43 | 1 |
| ORGANOGENESIS INC. | $33.48 | 1 |
| Lilly USA, LLC | $27.77 | 1 |
| Galderma Laboratories, L.P. | $24.14 | 1 |
| Aroa Biosurgery Incorporated | $23.81 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (52)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $33.74 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103718816 | CMS |
| ABBVIE INC. | $25.33 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103718818 | CMS |
| ABBVIE INC. | $24.02 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103718820 | CMS |
| ABBVIE INC. | $23.78 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103718822 | CMS |
| ABBVIE INC. | $23.50 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103718824 | CMS |
| ABBVIE INC. | $20.79 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103718826 | CMS |
| ABBVIE INC. | $26.09 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103718828 | CMS |
| ABBVIE INC. | $28.02 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103718830 | CMS |
| ABBVIE INC. | $26.12 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103718832 | CMS |
| ABBVIE INC. | $21.03 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103718834 | CMS |
| ABBVIE INC. | $20.76 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103718836 | CMS |
| ABBVIE INC. | $31.56 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103718838 | CMS |
| ABBVIE INC. | $33.39 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103718840 | CMS |
| ABBVIE INC. | $30.98 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103718842 | CMS |
| ABBVIE INC. | $32.25 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103718844 | CMS |
| ABBVIE INC. | $22.05 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103718846 | CMS |
| ABBVIE INC. | $31.15 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103718848 | CMS |
| ABBVIE INC. | $22.57 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103718850 | CMS |
| ABBVIE INC. | $33.92 | 08/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103718852 | CMS |
| ABBVIE INC. | $20.86 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103718854 | CMS |
| ABBVIE INC. | $13.84 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103718856 | CMS |
| ABBVIE INC. | $24.00 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103718858 | CMS |
| ABBVIE INC. | $20.57 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103718860 | CMS |
| ABBVIE INC. | $32.42 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103718862 | CMS |
| ABBVIE INC. | $30.24 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103718864 | CMS |
| ABBVIE INC. | $30.57 | 10/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103718866 | CMS |
| ABBVIE INC. | $29.12 | 11/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103718868 | CMS |
| ABBVIE INC. | $34.84 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103718870 | CMS |
| Aroa Biosurgery Incorporated | $23.81 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1088815637 | CMS |
| Galderma Laboratories, L.P. | $24.14 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145297101 | CMS |
| LifeNet Health | $35.43 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153024260 | CMS |
| Lilly USA, LLC | $27.77 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136149948 | CMS |
| MERZ NORTH AMERICA, INC. | $40.95 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146368989 | CMS |
| MERZ NORTH AMERICA, INC. | $35.00 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146368987 | CMS |
| Novo Nordisk Inc | $24.31 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096995660 | CMS |
| Novo Nordisk Inc | $20.83 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096578471 | CMS |
| Novo Nordisk Inc | $20.41 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097727169 | CMS |
| Organogenesis Inc. | $33.48 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145427144 | CMS |
| REVANCE THERAPEUTICS, INC. | $33.38 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147917581 | CMS |
| REVANCE THERAPEUTICS, INC. | $32.94 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147917583 | CMS |
| REVANCE THERAPEUTICS, INC. | $17.67 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147917585 | CMS |
| Solventum Corporation | $46.81 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144067990 | CMS |
| Solventum Corporation | $274.30 | 02/26/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1144067996 | CMS |
| Solventum Corporation | $153.98 | 02/28/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1144067994 | CMS |
| Solventum Corporation | $77.04 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144067988 | CMS |
| Solventum Corporation | $259.47 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144067982 | CMS |
| Solventum Corporation | $114.89 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144067984 | CMS |
| Solventum Corporation | $198.96 | 04/03/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1144067986 | CMS |
| Solventum Corporation | $30.94 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144067992 | CMS |
| TELA Bio, Inc. | $15.21 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154189874 | CMS |
| TELA Bio, Inc. | $24.30 | 02/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154189876 | CMS |
| TELA Bio, Inc. | $25.23 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154189878 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.